These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
678 related articles for article (PubMed ID: 28133550)
1. The Contribution of Longhena F; Faustini G; Missale C; Pizzi M; Spano P; Bellucci A Neural Plast; 2017; 2017():5012129. PubMed ID: 28133550 [TBL] [Abstract][Full Text] [Related]
2. From α-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease. Bellucci A; Zaltieri M; Navarria L; Grigoletto J; Missale C; Spano P Brain Res; 2012 Oct; 1476():183-202. PubMed ID: 22560500 [TBL] [Abstract][Full Text] [Related]
3. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats. Van Den Berge N; Ferreira N; Gram H; Mikkelsen TW; Alstrup AKO; Casadei N; Tsung-Pin P; Riess O; Nyengaard JR; Tamgüney G; Jensen PH; Borghammer P Acta Neuropathol; 2019 Oct; 138(4):535-550. PubMed ID: 31254094 [TBL] [Abstract][Full Text] [Related]
4. Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease. Faustini G; Longhena F; Varanita T; Bubacco L; Pizzi M; Missale C; Benfenati F; Björklund A; Spano P; Bellucci A Acta Neuropathol; 2018 Oct; 136(4):621-639. PubMed ID: 30046897 [TBL] [Abstract][Full Text] [Related]
5. α-Synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's disease. Bellucci A; Navarria L; Zaltieri M; Missale C; Spano P Brain Res; 2012 Jan; 1432():95-113. PubMed ID: 22153624 [TBL] [Abstract][Full Text] [Related]
6. The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson's disease. Vargas JY; Grudina C; Zurzolo C Ageing Res Rev; 2019 Mar; 50():89-101. PubMed ID: 30690184 [TBL] [Abstract][Full Text] [Related]
7. Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice. Luo Z; Ahlers-Dannen KE; Spicer MM; Yang J; Alberico S; Stevens HE; Narayanan NS; Fisher RA JCI Insight; 2019 May; 5(13):. PubMed ID: 31120439 [TBL] [Abstract][Full Text] [Related]
8. Synaptic dysfunction in Parkinson's disease. Picconi B; Piccoli G; Calabresi P Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072 [TBL] [Abstract][Full Text] [Related]
9. Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson's Disease. Cardinale A; Calabrese V; de Iure A; Picconi B Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204581 [TBL] [Abstract][Full Text] [Related]
10. Initiation and propagation of α-synuclein aggregation in the nervous system. Hijaz BA; Volpicelli-Daley LA Mol Neurodegener; 2020 Mar; 15(1):19. PubMed ID: 32143659 [TBL] [Abstract][Full Text] [Related]
11. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein. Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536 [TBL] [Abstract][Full Text] [Related]
12. Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease. Phan JA; Stokholm K; Zareba-Paslawska J; Jakobsen S; Vang K; Gjedde A; Landau AM; Romero-Ramos M Sci Rep; 2017 Jul; 7(1):6363. PubMed ID: 28743955 [TBL] [Abstract][Full Text] [Related]
13. Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease? Schulz-Schaeffer WJ Biomolecules; 2015 Jul; 5(3):1467-79. PubMed ID: 26193328 [TBL] [Abstract][Full Text] [Related]
14. α-Synuclein and dopamine at the crossroads of Parkinson's disease. Venda LL; Cragg SJ; Buchman VL; Wade-Martins R Trends Neurosci; 2010 Dec; 33(12):559-68. PubMed ID: 20961626 [TBL] [Abstract][Full Text] [Related]
15. Chronic nigral neuromodulation aggravates behavioral deficits and synaptic changes in an α-synuclein based rat model for Parkinson's disease. Torre-Muruzabal T; Devoght J; Van den Haute C; Brône B; Van der Perren A; Baekelandt V Acta Neuropathol Commun; 2019 Oct; 7(1):160. PubMed ID: 31640762 [TBL] [Abstract][Full Text] [Related]
16. Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit. Tozzi A; Sciaccaluga M; Loffredo V; Megaro A; Ledonne A; Cardinale A; Federici M; Bellingacci L; Paciotti S; Ferrari E; La Rocca A; Martini A; Mercuri NB; Gardoni F; Picconi B; Ghiglieri V; De Leonibus E; Calabresi P Brain; 2021 Dec; 144(11):3477-3491. PubMed ID: 34297092 [TBL] [Abstract][Full Text] [Related]
17. Synaptic failure and α-synuclein. Calo L; Wegrzynowicz M; Santivañez-Perez J; Grazia Spillantini M Mov Disord; 2016 Feb; 31(2):169-77. PubMed ID: 26790375 [TBL] [Abstract][Full Text] [Related]
18. Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson's disease. Acosta SA; Tajiri N; de la Pena I; Bastawrous M; Sanberg PR; Kaneko Y; Borlongan CV J Cell Physiol; 2015 May; 230(5):1024-32. PubMed ID: 25251017 [TBL] [Abstract][Full Text] [Related]
19. α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies. Henderson MX; Trojanowski JQ; Lee VM Neurosci Lett; 2019 Sep; 709():134316. PubMed ID: 31170426 [TBL] [Abstract][Full Text] [Related]
20. Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson's disease. Kohl Z; Ben Abdallah N; Vogelgsang J; Tischer L; Deusser J; Amato D; Anderson S; Müller CP; Riess O; Masliah E; Nuber S; Winkler J Neurobiol Dis; 2016 Jan; 85():206-217. PubMed ID: 26523794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]